Nano-X is working to multiply the value of its top line in 2024. Its stock price will likely follow its sales upward at least part of the way. Its business model hasn't proven itself just yet, which ...
Nano-X is an under-the-radar medical device company that may very well transform healthcare for a billion people around the world. The stock went up 68% on May 1. Don't worry about the short-term ...
Nano-X Imaging received FDA 510(k) clearance for its multi-source Nanox.ARC scanner, disproving claims of fraud and sparking a rally in shares. Despite FDA approval, Nano-X's stock has fallen 53% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results